{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-045513","form_type":"8-K","ticker":"CNTX","cik":"0001842952","company_name":"Context Therapeutics Inc.","filed_at":"2025-10-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.765385+00:00","generated_at":"2026-05-17T03:17:03.141663+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Context Therapeutics regains Nasdaq minimum bid price compliance","bullets":["Received Nasdaq letter on Oct 17, 2025 confirming compliance regained after 10 consecutive business days with closing bid price at or above $1.00.","Company had been noncompliant since Feb 27, 2025; granted extension to Feb 23, 2026.","Nasdaq considers the matter closed; delisting risk removed.","Stock ticker CNTX trades on Nasdaq under Minimum Bid Price Rule 5550(a)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-045513","json":"https://secwatch.observer/filing/0001628280-25-045513.json","markdown":"https://secwatch.observer/filing/0001628280-25-045513.md","text":"https://secwatch.observer/filing/0001628280-25-045513.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1842952/000162828025045513/0001628280-25-045513-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1842952/000162828025045513/cntx-20251017.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:17:03.141663+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}